String of appointments to BIA Board
pharmafile | October 15, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â BIA, appointmentsÂ
The BioIndustry Association has appointed Kevin Cox, Donna Hackett, Jane Osbourn, Stephen Taylor, Patrick Verheyen and Tim Watts to its Board of directors.
In addition, John Brown and Ian Tomlinson (pictured) have been re-appointed. The new and re-appointed Board members will serve from 1 January 2014 for a term of three years.
BIA chairman Edward Hodgkin said: “I am delighted to welcome our new Board members and congratulate our re-appointed Board members. The appointees are recognised leaders of our industry and I look forward to working with them to help the BIA meet the needs of the bioscience sector in Europe’s strongest bioscience cluster.
“I would also like to thank Janis Clayton, Jeremy Haigh, Keith Martin, Geoff Newman and Peter Nolan who are standing down at the end of the year for their service to the BIA and its members.”
Steve Bates, BIA chief executive added: “It is a privilege to work with such heavyweight talent from across our sector. The BIA Board has international reputation in research and development, business development, biopharmaceutical manufacturing and finance.”
The new and re-appointed BIA members in full are:
- John Brown, Non-executive director, Vectura Group plc
- Kevin Cox, chief executive, Imanova Ltd
- Donna Hackett, director, KDH BioManagement
- Jane Osbourn, VP Research and Development Biosuperiors, MedImmune
- Stephen Taylor, Commercial director, Fujifilm Diosynth Biotechnologies
- Ian Tomlinson, senior VP and head of Worldwide Business Development (WWBD) and Biopharmaceuticals R&D, GSK
- Patrick Verheyen, head, Johnson & Johnson Innovation, London
- Tim Watts, chief financial officer, Oxford BioMedica plc
Related Content
Sanofi axes four major players from its executive committee
Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief …
Dr Richard Torbett is named as the new Chief Executive of the ABPI
The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its …
Insys Therapeutics names current CFO Andrew Long as company’s new CEO
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s …
